Guided Therapeutics (GTHP) Operating Expenses (2010 - 2025)
Guided Therapeutics recorded quarterly Operating Expenses of $1.2 million in Q4 2025, up 124.62% quarter-over-quarter from $520000.0 in Q3 2025, and up 119.55% year-over-year from $532000.0 in Q4 2024.
Guided Therapeutics' Operating Expenses history runs 16 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Operating Expenses rose 119.55% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $2.9 million (up 39.46% YoY), while the FY2025 annual figure was $2.9 million, up 39.48% from the prior year.
- Operating Expenses came in at $1.2 million for Q4 2025 at Guided Therapeutics, up from $520000.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.5 million in Q2 2023 to a low of $363000.0 in Q1 2024.
- A 5-year average of $706850.0 and a median of $591000.0 in 2021 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses soared 240.08% in 2021 and tumbled 57.59% in 2024, its largest moves.
- Guided Therapeutics' Operating Expenses stood at $476000.0 in 2021, then soared by 82.56% to $869000.0 in 2022, then plunged by 42.35% to $501000.0 in 2023, then grew by 6.19% to $532000.0 in 2024, then surged by 119.55% to $1.2 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.2 million, $520000.0, and $842000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 822.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -668.50 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 495.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.46 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 380.30 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 842,000.00 |
| Mar 31, 2025 | 414,000.00 |
| Dec 31, 2024 | 532,000.00 |
| Sep 30, 2024 | 561,000.00 |
| Jun 30, 2024 | 655,000.00 |
| Mar 31, 2024 | 363,000.00 |
| Dec 31, 2023 | 501,000.00 |
| Sep 30, 2023 | 619,000.00 |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 856,000.00 |
| Dec 31, 2022 | 869,000.00 |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 721,000.00 |
| Mar 31, 2022 | 447,000.00 |
| Dec 31, 2021 | 476,000.00 |
| Sep 30, 2021 | 464,000.00 |
| Jun 30, 2021 | 563,000.00 |
| Mar 31, 2021 | 823,000.00 |
| Dec 31, 2020 | 374,000.00 |
| Sep 30, 2020 | 218,000.00 |
| Jun 30, 2020 | 363,000.00 |
| Mar 31, 2020 | 242,000.00 |
| Dec 31, 2019 | 177,000.00 |
| Sep 30, 2019 | 189,000.00 |
| Jun 30, 2019 | 263,000.00 |
| Mar 31, 2019 | 274,000.00 |
| Dec 31, 2018 | 405,000.00 |
| Sep 30, 2018 | 236,000.00 |
| Jun 30, 2018 | 498,000.00 |
| Mar 31, 2018 | 377,000.00 |
| Dec 31, 2017 | 503,000.00 |
| Sep 30, 2017 | 1.28 Mn |
| Jun 30, 2017 | 538,000.00 |
| Mar 31, 2017 | 519,000.00 |
| Dec 31, 2016 | 925,000.00 |
| Sep 30, 2016 | 689,000.00 |
| Jun 30, 2016 | 994,000.00 |
| Mar 31, 2016 | 1.32 Mn |
| Dec 31, 2015 | 1.80 Mn |
| Sep 30, 2015 | 1.71 Mn |
| Jun 30, 2015 | 1.51 Mn |
| Mar 31, 2015 | 1.51 Mn |
| Dec 31, 2014 | 2.17 Mn |
| Sep 30, 2014 | 2.44 Mn |
| Jun 30, 2014 | 1.97 Mn |
| Mar 31, 2014 | 2.03 Mn |
| Dec 31, 2013 | 1.53 Mn |
| Sep 30, 2013 | 1.67 Mn |
| Jun 30, 2013 | 1.96 Mn |
| Mar 31, 2013 | 2.02 Mn |
| Dec 31, 2012 | 2.19 Mn |
| Sep 30, 2012 | 1.65 Mn |
| Jun 30, 2012 | 2.02 Mn |
| Mar 31, 2012 | 1.71 Mn |
| Dec 31, 2011 | 3.70 Mn |
| Sep 30, 2011 | 3.67 Mn |
| Jun 30, 2011 | 1.40 Mn |
| Mar 31, 2011 | 1.51 Mn |
| Jun 30, 2010 | 1.34 Mn |